AIM
BSX icon

Advyzon Investment Management’s Boston Scientific BSX Stock Holding History

Advyzon Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,231
Closed -$203K – 763
2026
Q1 		$203K Buy
+3,231
New +$258K 0.02% 658
2025
Q3 		– Sell
-3,502
Closed -$376K – 479
2025
Q2 		$376K Buy
3,502
+649
+23% +$65.7K 0.08% 219
2025
Q1 		$288K Buy
+2,853
New +$287K 0.1% 192

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advyzon Investment Management's BSX Position: Q2 2026 in Review

Advyzon Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,231 shares — an estimated $203K sold.

Advyzon Investment Management first reported a position in BSX in Q1 2025 and held it in 3 quarters. The position peaked at $376K in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Advyzon Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Advyzon Investment Management sold 3,231 Boston Scientific shares in Q2 2026, an estimated $203K.
  • Advyzon Investment Management first reported a position in Boston Scientific in Q1 2025 and held it in 3 quarters.
  • Advyzon Investment Management's Boston Scientific position peaked at $376K in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.